HOME >> BIOLOGY >> NEWS
"Berry, berry, berrygood!"

New Orleans -- Red berry fruits -- such as the elderberry, chokeberry and bilberry -- have been used in folk medicine in Europe and North America for centuries. Hippocrates referred to the elderberry tree as his medicine chest while less famous healers have used the fruit as anti-inflammatory, anti-rheumatic, diuretic and laxative agents, as well as for the treatment of dysentery, stomach ailments, scurvy and urinary tract problems.

The berries contain a unique and complex chemical composition and are all rich in flavonoids, polyphenols and anthocynanins. The anthocyanins are responsible for the red, purple and blue pigments of the berries and hold the most promising properties for human health. Since anthocyanins have been shown to be powerful anti-oxidants, scientific reports about their anti-inflammatory, anti-ulcerative, anti-viral, and anti-cancer properties is not surprising, albeit more work needs to be done.

In recent years, the simple chemical nitric oxide (NO) has been shown to play an enormous role in the function of all arteries in health and disease. NO is produced by endothelial cells, which line the inner surface of all blood vessels. NO is a potent relaxing agent of arterial smooth muscle. It plays a major role in keeping the blood pressure of an individual from becoming dangerously high and in preventing blood vessels from spasming. In addition, NO inhibits the development of blood clots and the early processes of atherosclerosis.

Superoxide belongs to a family of reactive chemicals known as oxygen radicals, reactive oxygen species (ROS) or oxidants, as they are commonly referred to in lay literature. These radicals generally promote spasm, blood clot formation and atherosclerosis in arteries. Oxygen radical generation has been shown to be increased in a variety of cardiovascular diseases and also appears to play a detrimental role in cancers, diabetes and inflammatory conditions. Vitamins C and E are known to scavenge or s
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-967-2751
American Physiological Society
22-Apr-2002


Page: 1 2 3 4

Related biology news :

1. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
2. Chemical signals health of brain cells Symposium
3. The birth of reproductive health: A difficult delivery
4. Ventilation in bars, casinos doesnt control health risk for hospitality workers
5. Diabetics face fewer healthy food choices in some urban areas
6. Human health risks in space flight focus of research internships
7. Study shows impact of emotionally healthy fathers when mothers poor mental health affects children
8. Ottawas leadership in biomedical and health research has paid off
9. Oxygen sensing in worms may hold key to healthy blood pressure in humans
10. Make a splash for public health this summer
11. Endurance exercise found to be equally effective as diuretics in improving cardiac health

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Berry berry berrygood

(Date:4/27/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... first week of May, 2015 and will be fulfilling ... Gino Pereira , Chief Executive Officer ... as Wocket® enters the consumer market. We would like ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/14/2015)... 2015  HYPR Corp. today announced it has ... Alliance tm , an industry consortium transforming online ... share technology and collaborate to deliver open specifications ... secure and private, and easier to use. ... protects sensitive user information and eliminates the dependency ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3
(Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
(Date:5/21/2015)... W. R. Grace & Co. (NYSE: ... Germany has received good manufacturing practice (GMP) certification ... Pharmaceutical Excipient Council (IPEC) Foundation. , ... FP brand of pharmaceutical grade excipient silica gels ... Bay, Maryland (USA) and Sorocaba, Brazil locations. The ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... May 20, 2015 Research and Markets ... of the "2015 Global Survey on Flow ... The primary goal of this research ... instruments and reagents. Key information the survey seeks ... of flow cytometers, predominantly used applications for flow ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2
Cached News: